Enhanced FLT3-AKT signaling in CBL-/- CBL-B-/- cDC1s suggests that attenuation of FLT3-AKT signaling may normalize cDC1 homeostasis and cure liver inflammatory disease in CBL-/-CBL-B-/- mice. This evidence concerns the gene CBL and liver disorder.